Profile | GDS5420 / 48659_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 311.69 | 59 |
GSM1296119 | B_lesional_pre-dose | 103.8 | 41 |
GSM1296076 | C_lesional_pre-dose | 72.57 | 37 |
GSM1296092 | D_lesional_pre-dose | 125.66 | 47 |
GSM1296103 | E_lesional_pre-dose | 310.29 | 60 |
GSM1296078 | F_lesional_pre-dose | 65.31 | 36 |
GSM1296107 | G_lesional_pre-dose | 111.99 | 42 |
GSM1296109 | H_lesional_pre-dose | 270.1 | 56 |
GSM1296080 | I_lesional_pre-dose | 210.84 | 54 |
GSM1296090 | J_lesional_pre-dose | 101.68 | 43 |
GSM1296074 | K_lesional_pre-dose | 83.52 | 41 |
GSM1296111 | L_lesional_pre-dose | 94.04 | 38 |
GSM1296099 | M_lesional_pre-dose | 234.42 | 55 |
GSM1296086 | O_lesional_pre-dose | 121.56 | 46 |
GSM1296117 | P_lesional_pre-dose | 127.73 | 43 |
GSM1296113 | Q_lesional_pre-dose | 134.75 | 43 |
GSM1296096 | R_lesional_pre-dose | 226.31 | 55 |
GSM1296105 | S_lesional_pre-dose | 182.89 | 50 |
GSM1296098 | T_lesional_pre-dose | 461.79 | 66 |
GSM1296101 | U_lesional_pre-dose | 226.49 | 54 |
GSM1296121 | V_lesional_pre-dose | 108.22 | 42 |
GSM1296088 | W_lesional_pre-dose | 149.08 | 48 |
GSM1296082 | X_lesional_pre-dose | 111.21 | 45 |
GSM1296115 | Y_lesional_pre-dose | 94.95 | 39 |
GSM1296084 | Z_lesional_pre-dose | 140.08 | 47 |
GSM1296072 | B_lesional_day8 | 119.62 | 43 |
GSM1296069 | L_lesional_day8 | 111.31 | 40 |
GSM1296071 | P_lesional_day8 | 123.08 | 42 |
GSM1296070 | Y_lesional_day8 | 109.67 | 40 |
GSM1296073 | V_lesional_day8 | 75.8 | 36 |
GSM1296034 | A_lesional_day15 | 468.99 | 66 |
GSM1296041 | G_lesional_day15 | 93.06 | 39 |
GSM1296035 | R_lesional_day15 | 262.71 | 57 |
GSM1296038 | U_lesional_day15 | 157.84 | 49 |
GSM1296047 | B_lesional_day15 | 100.18 | 39 |
GSM1296039 | E_lesional_day15 | 164.03 | 50 |
GSM1296042 | H_lesional_day15 | 122.37 | 42 |
GSM1296043 | L_lesional_day15 | 142.69 | 45 |
GSM1296037 | M_lesional_day15 | 298.15 | 58 |
GSM1296046 | P_lesional_day15 | 85.67 | 36 |
GSM1296044 | Q_lesional_day15 | 134.34 | 43 |
GSM1296045 | Y_lesional_day15 | 111.62 | 40 |
GSM1296025 | C_lesional_day15 | 132.08 | 46 |
GSM1296033 | D_lesional_day15 | 150.65 | 48 |
GSM1296027 | I_lesional_day15 | 129.94 | 48 |
GSM1296032 | J_lesional_day15 | 110.07 | 43 |
GSM1296024 | K_lesional_day15 | 164.93 | 50 |
GSM1296031 | W_lesional_day15 | 157.91 | 48 |
GSM1296028 | X_lesional_day15 | 122.19 | 45 |
GSM1296029 | Z_lesional_day15 | 138.09 | 47 |
GSM1296026 | F_lesional_day15 | 103.11 | 42 |
GSM1296030 | O_lesional_day15 | 135.1 | 48 |
GSM1296040 | S_lesional_day15 | 297.57 | 59 |
GSM1296036 | T_lesional_day15 | 355.33 | 61 |
GSM1296048 | V_lesional_day15 | 102.91 | 41 |
GSM1296059 | A_lesional_day43 | 286.25 | 59 |
GSM1296066 | G_lesional_day43 | 97 | 39 |
GSM1296060 | R_lesional_day43 | 217.09 | 54 |
GSM1296063 | U_lesional_day43 | 120.74 | 44 |
GSM1296064 | E_lesional_day43 | 135.91 | 47 |
GSM1296067 | H_lesional_day43 | 182.82 | 49 |
GSM1296062 | M_lesional_day43 | 301.34 | 59 |
GSM1296068 | Q_lesional_day43 | 129.25 | 42 |
GSM1296050 | C_lesional_day43 | 86.34 | 39 |
GSM1296057 | D_lesional_day43 | 270.4 | 57 |
GSM1296052 | I_lesional_day43 | 86.17 | 41 |
GSM1296054 | J_lesional_day43 | 164.33 | 48 |
GSM1296049 | K_lesional_day43 | 111.45 | 43 |
GSM1296055 | W_lesional_day43 | 211.15 | 52 |
GSM1296053 | X_lesional_day43 | 145.12 | 47 |
GSM1296058 | Z_lesional_day43 | 250.07 | 56 |
GSM1296051 | F_lesional_day43 | 80.43 | 39 |
GSM1296056 | O_lesional_day43 | 190.91 | 53 |
GSM1296065 | S_lesional_day43 | 166.05 | 49 |
GSM1296061 | T_lesional_day43 | 514.82 | 67 |
GSM1296095 | A_non-lesional_pre-dose | 155.64 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 91.81 | 38 |
GSM1296077 | C_non-lesional_pre-dose | 150.22 | 49 |
GSM1296093 | D_non-lesional_pre-dose | 142.61 | 46 |
GSM1296104 | E_non-lesional_pre-dose | 159.13 | 49 |
GSM1296079 | F_non-lesional_pre-dose | 102.31 | 42 |
GSM1296108 | G_non-lesional_pre-dose | 137.41 | 45 |
GSM1296110 | H_non-lesional_pre-dose | 169.64 | 47 |
GSM1296081 | I_non-lesional_pre-dose | 127.67 | 47 |
GSM1296091 | J_non-lesional_pre-dose | 107.39 | 43 |
GSM1296075 | K_non-lesional_pre-dose | 72.47 | 37 |
GSM1296112 | L_non-lesional_pre-dose | 153.7 | 45 |
GSM1296100 | M_non-lesional_pre-dose | 266.66 | 56 |
GSM1296087 | O_non-lesional_pre-dose | 66.1 | 37 |
GSM1296118 | P_non-lesional_pre-dose | 129.7 | 43 |
GSM1296114 | Q_non-lesional_pre-dose | 112.88 | 41 |
GSM1296097 | R_non-lesional_pre-dose | 201.04 | 52 |
GSM1296106 | S_non-lesional_pre-dose | 177.47 | 49 |
GSM1296102 | U_non-lesional_pre-dose | 229.15 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 110.96 | 41 |
GSM1296089 | W_non-lesional_pre-dose | 153.63 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 235.15 | 55 |
GSM1296116 | Y_non-lesional_pre-dose | 113.37 | 40 |
GSM1296085 | Z_non-lesional_pre-dose | 97.44 | 41 |